Cargando…
Correction to: Identifying Patients for Self-Administration of Omalizumab
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898316/ https://www.ncbi.nlm.nih.gov/pubmed/36401056 http://dx.doi.org/10.1007/s12325-022-02373-1 |
| _version_ | 1784882400712458240 |
|---|---|
| author | Murphy, Kevin R. Winders, Tonya Smith, Brandy Millette, Lauren Chipps, Bradley E. |
| author_facet | Murphy, Kevin R. Winders, Tonya Smith, Brandy Millette, Lauren Chipps, Bradley E. |
| author_sort | Murphy, Kevin R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9898316 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98983162023-02-05 Correction to: Identifying Patients for Self-Administration of Omalizumab Murphy, Kevin R. Winders, Tonya Smith, Brandy Millette, Lauren Chipps, Bradley E. Adv Ther Correction Springer Healthcare 2022-11-18 2023 /pmc/articles/PMC9898316/ /pubmed/36401056 http://dx.doi.org/10.1007/s12325-022-02373-1 Text en © Springer Healthcare Ltd., part of Springer Nature 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Murphy, Kevin R. Winders, Tonya Smith, Brandy Millette, Lauren Chipps, Bradley E. Correction to: Identifying Patients for Self-Administration of Omalizumab |
| title | Correction to: Identifying Patients for Self-Administration of Omalizumab |
| title_full | Correction to: Identifying Patients for Self-Administration of Omalizumab |
| title_fullStr | Correction to: Identifying Patients for Self-Administration of Omalizumab |
| title_full_unstemmed | Correction to: Identifying Patients for Self-Administration of Omalizumab |
| title_short | Correction to: Identifying Patients for Self-Administration of Omalizumab |
| title_sort | correction to: identifying patients for self-administration of omalizumab |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898316/ https://www.ncbi.nlm.nih.gov/pubmed/36401056 http://dx.doi.org/10.1007/s12325-022-02373-1 |
| work_keys_str_mv | AT murphykevinr correctiontoidentifyingpatientsforselfadministrationofomalizumab AT winderstonya correctiontoidentifyingpatientsforselfadministrationofomalizumab AT smithbrandy correctiontoidentifyingpatientsforselfadministrationofomalizumab AT millettelauren correctiontoidentifyingpatientsforselfadministrationofomalizumab AT chippsbradleye correctiontoidentifyingpatientsforselfadministrationofomalizumab |